SCHEMBL7914883

SCHEMBL7914883

COc1ccc(-c2nnc(Nc3ccccc3)c3cc(C)c(C)cc23)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.62
LMNA P02545 1/20 0.62
TP53 P04637 5/20 0.58
KDR P35968 2/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
ENPP3 O14638 1/20 0.57
ALDH1A1 P00352 1/20 0.54
THRB P10828 1/20 0.54
HTT P42858 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
NPSR1 Q6W5P4 1/20 0.51
GPR174 Q9BXC1 1/20 0.50
ACP1 P24666 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.48
KDM4E B2RXH2 1/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
PPARG P37231 1/20 0.47
RECQL P46063 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7912095 0.90 MAPT (0.62) MAPTLMNATP53KDRMEN1
SCHEMBL7914832 0.89 MAPT (0.61) MAPTLMNATP53KDRMEN1
SCHEMBL7912315 0.88 NPSR1 (0.56) MAPTLMNATP53KDRENPP3
SCHEMBL7904976 0.87 MAPT (0.58) MAPTLMNATP53KDRMEN1
SCHEMBL7912137 0.87 NPSR1 (0.56) MAPTTP53KDRKMT2AENPP3
SCHEMBL7918628 0.87 MAPT (0.81) MAPTLMNATP53KDRMEN1
SCHEMBL7904917 0.84 ENPP3 (0.57) MAPTLMNATP53KDRENPP3
SCHEMBL7913364 0.84 KDR (0.58) MAPTLMNATP53KDRPOLB
SCHEMBL7904904 0.84 CA1 (0.50) MAPTLMNATP53KDRMEN1
SCHEMBL7915059 0.82 NPSR1 (0.52) MAPTLMNATP53KDRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207666-B1 TREATING PRECANCEROUS LESIONS BY ADMINISTERING 4-PHENYLPHTHALAZINE DERIVATIVE CELL PATHWAYS, INC. 2001-03-27 US disclosed